Cochrane Abstracts
Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Disease‐modifying Anti‐rheumatic Drugs for Rheumatoid Arthritis: a Systematic Review and Network Meta‐analysis." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/438879/1/Smectite_for_acute_infectious_diarrhoea_in_children:_Cochrane_systematic_review.
Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/1/Smectite_for_acute_infectious_diarrhoea_in_children:_Cochrane_systematic_review. Accessed July 17, 2025.
Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/1/Smectite_for_acute_infectious_diarrhoea_in_children:_Cochrane_systematic_review
Disease‐modifying Anti‐rheumatic Drugs for Rheumatoid Arthritis: a Systematic Review and Network Meta‐analysis [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 July 17]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/1/Smectite_for_acute_infectious_diarrhoea_in_children:_Cochrane_systematic_review.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Disease‐modifying anti‐rheumatic drugs for rheumatoid arthritis: a systematic review and network meta‐analysis
ID - 438879
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/438879/1/Smectite_for_acute_infectious_diarrhoea_in_children:_Cochrane_systematic_review
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
